US20110196039A9
(en)
*
|
1994-10-05 |
2011-08-11 |
Kaesemeyer Wayne H |
Controlled release arginine formulations
|
WO1999029314A1
(en)
*
|
1997-12-08 |
1999-06-17 |
Bristol-Myers Squibb Company |
Novel salts of metformin and method
|
US6099859A
(en)
*
|
1998-03-20 |
2000-08-08 |
Andrx Pharmaceuticals, Inc. |
Controlled release oral tablet having a unitary core
|
US20030153607A1
(en)
*
|
1998-11-12 |
2003-08-14 |
Smithkline Beecham P.L.C. |
Novel composition and use
|
US20040081697A1
(en)
*
|
1998-11-12 |
2004-04-29 |
Smithkline Beecham P.L.C. |
Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent
|
US20040102486A1
(en)
*
|
1998-11-12 |
2004-05-27 |
Smithkline Beecham Corporation |
Novel method of treatment
|
JP2003514011A
(ja)
*
|
1999-11-16 |
2003-04-15 |
スミスクライン ビーチャム パブリック リミテッド カンパニー |
チアゾリジンジオン−塩酸メトホルミンを含む医薬組成物
|
AR030920A1
(es)
|
1999-11-16 |
2003-09-03 |
Smithkline Beecham Plc |
Composiciones farmaceuticas para el tratamiento de la diabetes mellitus y condiciones asociadas con la diabetes mellitus, y procedimientos para preparar dichas composiciones
|
AU767812B2
(en)
|
2000-02-04 |
2003-11-27 |
Depomed, Inc. |
Shell-and-core dosage form approaching zero-order drug release
|
US8012504B2
(en)
|
2000-04-28 |
2011-09-06 |
Reckitt Benckiser Inc. |
Sustained release of guaifenesin combination drugs
|
US6955821B2
(en)
*
|
2000-04-28 |
2005-10-18 |
Adams Laboratories, Inc. |
Sustained release formulations of guaifenesin and additional drug ingredients
|
US7838032B2
(en)
*
|
2000-04-28 |
2010-11-23 |
Reckitt Benckiser Inc. |
Sustained release of guaifenesin
|
US7985420B2
(en)
|
2000-04-28 |
2011-07-26 |
Reckitt Benckiser Inc. |
Sustained release of guaifenesin combination drugs
|
USRE44145E1
(en)
|
2000-07-07 |
2013-04-09 |
A.V. Topchiev Institute Of Petrochemical Synthesis |
Preparation of hydrophilic pressure sensitive adhesives having optimized adhesive properties
|
FR2811571B1
(fr)
*
|
2000-07-11 |
2002-10-11 |
Flamel Tech Sa |
Composition pharmaceutique orale, permettant la liberation controlee et l'absorption prolongee d'un principe actif
|
AU2001213150A1
(en)
*
|
2000-08-03 |
2002-02-18 |
Olga Evgenievna Kolesova |
Composition of metformin with succinic acid or salts thereof and method for treating diabetes
|
US6531158B1
(en)
*
|
2000-08-09 |
2003-03-11 |
Impax Laboratories, Inc. |
Drug delivery system for enhanced bioavailability of hydrophobic active ingredients
|
DK1322158T3
(da)
*
|
2000-10-02 |
2012-11-19 |
Usv Ltd |
Farmaceutiske præparater med langvarig frigivelse, som indeholder metformin, og fremgangsmåde til fremstilling deraf
|
US6866866B1
(en)
|
2000-11-03 |
2005-03-15 |
Andrx Labs, Llc |
Controlled release metformin compositions
|
US6790459B1
(en)
|
2000-11-03 |
2004-09-14 |
Andrx Labs, Llc |
Methods for treating diabetes via administration of controlled release metformin
|
MXPA03003994A
(es)
|
2000-11-03 |
2004-09-10 |
Andrx Labs Llc |
Composiciones de metformina de liberacion controlada.
|
US20060034922A1
(en)
*
|
2000-11-03 |
2006-02-16 |
Andrx Labs, Llc |
Controlled release metformin compositions
|
FR2816840B1
(fr)
|
2000-11-17 |
2004-04-09 |
Flamel Tech Sa |
Medicament a base de microcapsules d'anti-hyperclycemiant a liberation prolongee et son procede de preparation
|
FR2818906B1
(fr)
*
|
2000-12-29 |
2004-04-02 |
Dospharma |
Association medicamenteuse d'une biguanine et d'un transporteur, par exemple de metformine et d'arginine
|
EP1738751B1
(en)
*
|
2001-01-12 |
2011-05-11 |
Sun Pharma Advanced Research Company Ltd |
Spaced drug delivery system
|
KR200249057Y1
(ko)
*
|
2001-03-22 |
2001-10-19 |
김진환 |
뚜껑, 받침대에 합체된 하수역류. 악취방지 장치
|
ATE526951T1
(de)
*
|
2001-04-10 |
2011-10-15 |
Sun Pharma Advanced Res Co Ltd |
Zubereitung zur getakteten freisetzung
|
US20050215727A1
(en)
|
2001-05-01 |
2005-09-29 |
Corium |
Water-absorbent adhesive compositions and associated methods of manufacture and use
|
US8840918B2
(en)
|
2001-05-01 |
2014-09-23 |
A. V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences |
Hydrogel compositions for tooth whitening
|
RU2276998C2
(ru)
|
2001-05-01 |
2006-05-27 |
Институт Нефтехимического Синтеза Имени А.В. Топчиева Российской Академии Наук |
Гидрогелевые композиции
|
US8541021B2
(en)
|
2001-05-01 |
2013-09-24 |
A.V. Topchiev Institute Of Petrochemical Synthesis |
Hydrogel compositions demonstrating phase separation on contact with aqueous media
|
US8206738B2
(en)
|
2001-05-01 |
2012-06-26 |
Corium International, Inc. |
Hydrogel compositions with an erodible backing member
|
FR2825023B1
(fr)
|
2001-05-23 |
2005-04-15 |
Flamel Tech Sa |
Forme pharmaceutique orale antidiabetique "une prise par jour"comprenant une biguanide et au moins un autre principe actif
|
US6524618B1
(en)
|
2001-06-12 |
2003-02-25 |
Vijai Kumar |
Directly compressible extended-release matrix formulation for metformin hydrochloride
|
WO2003004009A1
(en)
*
|
2001-07-02 |
2003-01-16 |
Geneva Pharmaceuticals, Inc. |
Pharmaceutical composition
|
WO2003011255A1
(en)
|
2001-07-04 |
2003-02-13 |
Sun Pharmaceutical Industries Limited |
Gastric retention controlled drug delivery system
|
JP2005525299A
(ja)
*
|
2001-09-14 |
2005-08-25 |
スコラー インコーポレイテッド |
アミノ酸調節性の長期放出投薬形態
|
IN192180B
(id)
*
|
2001-09-28 |
2004-03-06 |
Ranbaxy Lab |
|
US8101209B2
(en)
|
2001-10-09 |
2012-01-24 |
Flamel Technologies |
Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
|
US7612112B2
(en)
|
2001-10-25 |
2009-11-03 |
Depomed, Inc. |
Methods of treatment using a gastric retained gabapentin dosage
|
TWI312285B
(en)
|
2001-10-25 |
2009-07-21 |
Depomed Inc |
Methods of treatment using a gastric retained gabapentin dosage
|
EA200400628A1
(ru)
*
|
2001-11-06 |
2004-12-30 |
Рэнбакси Лабораториз Лимитед |
Таблетки метформина с контролируемым высвобождением активного компонента
|
IL146462A
(en)
*
|
2001-11-13 |
2015-02-26 |
Lycored Bio Ltd |
Prolonged-release preparations containing as an active compound and analapaxin hydrochloride
|
ITFI20010230A1
(it)
*
|
2001-11-29 |
2003-05-29 |
Menarini Int Operations Lu Sa |
Composizioni farmaceutiche per il trattamento del diabete mellito di tipo ii
|
AU2003202879A1
(en)
*
|
2002-01-04 |
2003-07-24 |
Ivax Research, Inc. |
Drug delivery system for sustained delivery of glipizide
|
US6682759B2
(en)
*
|
2002-02-01 |
2004-01-27 |
Depomed, Inc. |
Manufacture of oral dosage forms delivering both immediate-release and sustained-release drugs
|
GB0203296D0
(en)
*
|
2002-02-12 |
2002-03-27 |
Glaxo Group Ltd |
Novel composition
|
US8323692B2
(en)
*
|
2002-02-21 |
2012-12-04 |
Valeant International Bermuda |
Controlled release dosage forms
|
IL149055A0
(en)
*
|
2002-04-09 |
2002-11-10 |
Karma Pharm Ltd |
Extended release composition comprising as active compound venlafaxine hydrochloride
|
DE60325709D1
(de)
|
2002-04-09 |
2009-02-26 |
Flamel Tech Sa |
Orale wässrige suspension, mikrokapseln enthaltend, zur kontrollierten freisetzung von wirkstoffen
|
CA2480824A1
(fr)
|
2002-04-09 |
2003-10-16 |
Flamel Technologies |
Formulation pharmaceutique orale sous forme de suspension aqueuse de microcapsules permettant la liberation modifiee d'amoxicilline
|
WO2003099214A2
(en)
*
|
2002-05-23 |
2003-12-04 |
Andrx Corporation |
Biguanide formulations
|
KR100897890B1
(ko)
|
2002-06-17 |
2009-05-18 |
인벤티아 헬스케어 피브이티. 엘티디. |
티아졸리딘디온 및 바이구아나이드를 함유하는 다층 정제및 그의 제조 방법
|
US8637512B2
(en)
*
|
2002-07-29 |
2014-01-28 |
Glaxo Group Limited |
Formulations and method of treatment
|
US7214387B2
(en)
|
2002-08-02 |
2007-05-08 |
Penwest Pharmaceuticals Company |
Sustained release formulations of metformin
|
US7985422B2
(en)
*
|
2002-08-05 |
2011-07-26 |
Torrent Pharmaceuticals Limited |
Dosage form
|
US8268352B2
(en)
*
|
2002-08-05 |
2012-09-18 |
Torrent Pharmaceuticals Limited |
Modified release composition for highly soluble drugs
|
US8216609B2
(en)
*
|
2002-08-05 |
2012-07-10 |
Torrent Pharmaceuticals Limited |
Modified release composition of highly soluble drugs
|
US9060941B2
(en)
|
2002-09-20 |
2015-06-23 |
Actavis, Inc. |
Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
|
US7785627B2
(en)
|
2002-09-20 |
2010-08-31 |
Watson Pharmaceuticals, Inc. |
Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
|
US7959946B2
(en)
|
2002-09-20 |
2011-06-14 |
Watson Pharmaceuticals, Inc. |
Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
|
US20050048119A1
(en)
*
|
2002-09-20 |
2005-03-03 |
Avinash Nangia |
Controlled release composition with semi-permeable membrane and poloxamer flux enhancer
|
KR20120034211A
(ko)
|
2002-09-20 |
2012-04-10 |
안드렉스 랩스 엘엘씨 |
약제학적 정제
|
US8084058B2
(en)
|
2002-09-20 |
2011-12-27 |
Watson Pharmaceuticals, Inc. |
Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
|
UA80991C2
(en)
|
2002-10-07 |
2007-11-26 |
|
Solid preparation containing an insulin resistance improving drug and an active ingredient useful as a remedy for diabetes
|
US20040086566A1
(en)
*
|
2002-11-04 |
2004-05-06 |
Alpharma, Inc. |
Waxy matrix dosage forms
|
WO2004047718A2
(en)
*
|
2002-11-28 |
2004-06-10 |
Themis Laboratories Private Limited |
Process for manufacturing sustained release microbeads containing venlafaxine hci
|
US20040115265A1
(en)
*
|
2002-12-11 |
2004-06-17 |
Loutfy Benkerrour |
Multilayered tablet containing pravastatin and aspirin and method
|
CA2729967C
(en)
|
2002-12-13 |
2018-01-16 |
Schering-Plough Healthcare Products, Inc. |
Use of a transdermal or transmucosal ingredient delivery device
|
DE10260921A1
(de)
*
|
2002-12-20 |
2004-07-01 |
Röhm GmbH & Co. KG |
Verfahren zum Überziehen von Substraten für pharmazeutische Anwendungen mit einem Gemisch aus zwei filmbildenden Überzugsmitteln
|
TWI355276B
(en)
*
|
2003-01-14 |
2012-01-01 |
Akira Tsuji |
Gastrointestinal absorption enhancer mediated by p
|
CN100500130C
(zh)
*
|
2003-01-23 |
2009-06-17 |
株式会社太平洋 |
缓释制剂及其制备方法
|
EP1588708A4
(en)
|
2003-01-29 |
2006-03-01 |
Takeda Pharmaceutical |
METHOD FOR PRODUCING COATED PREPARATION
|
US20060210633A1
(en)
*
|
2003-04-03 |
2006-09-21 |
Sun Pharmaceutical Industries Limited |
Programmed drug delivery system
|
EP1648363B1
(en)
|
2003-07-03 |
2019-03-06 |
Corium International, Inc. |
Wound dressing, ingredient delivery device and iv hold-down, and method relating to same
|
US20050013863A1
(en)
*
|
2003-07-18 |
2005-01-20 |
Depomed, Inc., A Corporation Of The State Of California |
Dual drug dosage forms with improved separation of drugs
|
WO2005012346A1
(en)
*
|
2003-07-25 |
2005-02-10 |
Conjuchem, Inc. |
Long lasting insulin derivatives and methods thereof
|
PT1575565E
(pt)
|
2003-08-08 |
2010-03-03 |
Biovail Lab Int Srl |
Comprimido de libertação modificada de cloridrato de bupropiona
|
EP1510208A1
(en)
|
2003-08-22 |
2005-03-02 |
Fournier Laboratories Ireland Limited |
Pharmaceutical composition comprising a combination of metformin and statin
|
DE10359792A1
(de)
*
|
2003-12-19 |
2005-07-21 |
Bayer Technology Services Gmbh |
Mehrphasige Wirkstoffformulierung
|
WO2005063275A1
(en)
*
|
2003-12-23 |
2005-07-14 |
Musc Foundaton For Research Development |
Methods and compositions for the prevention and treatment of inflammatory diseases or conditions
|
EP1841414A1
(en)
*
|
2003-12-31 |
2007-10-10 |
Alpharma, Inc. |
Rosiglitazone and metformin formulations
|
EP1732513A2
(en)
*
|
2003-12-31 |
2006-12-20 |
Alpharma, Inc. |
Rosiglitazone formulations
|
EP1559419A1
(en)
*
|
2004-01-23 |
2005-08-03 |
Fournier Laboratories Ireland Limited |
Pharmaceutical formulations comprising metformin and a fibrate, and processes for their obtention
|
US8658201B2
(en)
|
2004-01-30 |
2014-02-25 |
Corium International, Inc. |
Rapidly dissolving film for delivery of an active agent
|
EP1734953A4
(en)
*
|
2004-03-02 |
2008-08-20 |
Abeille Pharmaceuticals Inc |
CO-PR PARATIONS OF KITS OF BIOACTIVE AGENTS
|
WO2005092293A1
(en)
*
|
2004-03-22 |
2005-10-06 |
Ranbaxy Laboratories Limited |
Formulations of metformin
|
JP4739189B2
(ja)
|
2004-04-14 |
2011-08-03 |
武田薬品工業株式会社 |
固形製剤
|
MEP25008A
(en)
*
|
2004-04-29 |
2010-10-10 |
Caldwell Galer Inc |
Topical methadone compositions and methods for using the same
|
PL1753398T3
(pl)
*
|
2004-06-10 |
2019-04-30 |
Glatt Air Techniques Inc |
Macierz o kontrolowanym uwalnianiu farmaceutycznej formulacji dawkowania
|
US20050285732A1
(en)
*
|
2004-06-25 |
2005-12-29 |
Sengupta Uttam K |
Radio frequency identification based system to track consumption of medication
|
US20060024368A1
(en)
*
|
2004-07-30 |
2006-02-02 |
Reza Fassihi |
Compressed composite delivery system for release-rate modulation of bioactives
|
AU2005271259B2
(en)
|
2004-08-05 |
2012-01-19 |
A.V. Topchiev Institute Of Petrochemical Synthesis |
Adhesive composition
|
WO2006038226A2
(en)
*
|
2004-10-08 |
2006-04-13 |
Rubicon Research Pvt. Ltd. |
Process for making a highly compressible controlled delivery compositions of metformin
|
EP1812920A1
(en)
*
|
2004-10-29 |
2007-08-01 |
Adhesives Research, Inc. |
Microscopic tagging system for security identification
|
US8012374B2
(en)
*
|
2004-11-04 |
2011-09-06 |
The University Of Cincinnati |
Slow-release inhibitor for corrosion control of metals
|
KR100760430B1
(ko)
*
|
2004-12-31 |
2007-10-04 |
한미약품 주식회사 |
당뇨병 치료제의 경구 투여용 서방성 복합 제제 및 이의제조 방법
|
US20060222709A1
(en)
*
|
2005-03-18 |
2006-10-05 |
Agi Therapeutics Research Ltd. |
Metformin methods and formulations for treating chronic constipation
|
AP2244A
(en)
*
|
2005-04-26 |
2011-06-24 |
Caldwell Galer Inc |
Topical methadone compositions and methods for using the same.
|
WO2006123213A1
(en)
*
|
2005-05-18 |
2006-11-23 |
Ranbaxy Laboratories Limited |
Modified release formulations of gliclazide
|
US20060275249A1
(en)
*
|
2005-06-03 |
2006-12-07 |
Jones Michael R |
Co-therapy for diabetic conditions
|
WO2007010847A1
(ja)
*
|
2005-07-15 |
2007-01-25 |
Kissei Pharmaceutical Co., Ltd. |
徐放製剤
|
ATE396710T1
(de)
*
|
2005-07-19 |
2008-06-15 |
Ethypharm Sa |
Gastroretentive zusammensetzungen und verfahren zur herstellung
|
US20070077305A1
(en)
*
|
2005-10-03 |
2007-04-05 |
Le Tien C |
Biocompatible polymeric matrix and preparation thereof
|
US20090176882A1
(en)
|
2008-12-09 |
2009-07-09 |
Depomed, Inc. |
Gastric retentive gabapentin dosage forms and methods for using same
|
EP1991210A1
(en)
*
|
2006-02-15 |
2008-11-19 |
Intec Pharma Ltd. |
A gastro-retentive system for the delivery of macromolecules
|
AU2013202441B2
(en)
*
|
2006-04-26 |
2016-02-25 |
Alphapharm Pty Ltd |
Controlled release formulations comprising uncoated discrete unit(s) and an extended release matrix
|
JP5826456B2
(ja)
*
|
2006-04-26 |
2015-12-02 |
アルファファーム ピーティーワイ リミテッド |
コーティングされていない分離したユニットおよび延長放出マトリクスを含む制御放出配合物
|
US20080095856A1
(en)
*
|
2006-05-12 |
2008-04-24 |
Jacobson Gunilla B |
Encapsulated Nanoparticles for Drug Delivery
|
CZ300698B6
(cs)
*
|
2006-06-16 |
2009-07-22 |
Zentiva, A. S. |
Tableta s obsahem metforminu
|
WO2008003093A2
(en)
*
|
2006-06-29 |
2008-01-03 |
Questcor Pharmaceuticals, Inc. |
Pharmaceutical compositions and related methods of treatment
|
KR100791844B1
(ko)
*
|
2006-06-30 |
2008-01-07 |
주식회사유한양행 |
메트포르민 또는 그의 염을 함유하는 서방성 제제 및 그의제조방법
|
ES2618500T3
(es)
|
2006-10-20 |
2017-06-21 |
Neurendo Pharma, Llc |
Método para restaurar el efecto incretina
|
CN101652131A
(zh)
|
2007-01-29 |
2010-02-17 |
韩兀制药株式会社 |
N,n-二甲基亚氨基二碳亚氨酸二酰胺乙酸盐、其制备方法和包含其的药物组合物
|
US20070172525A1
(en)
*
|
2007-03-15 |
2007-07-26 |
Ramesh Sesha |
Anti-diabetic combinations
|
US20080064701A1
(en)
*
|
2007-04-24 |
2008-03-13 |
Ramesh Sesha |
Anti-diabetic combinations
|
KR101381999B1
(ko)
*
|
2007-07-06 |
2014-04-14 |
동아에스티 주식회사 |
위염 치료제의 효력을 극대화시키기 위한 가용화 위체류시스템 매트릭스 제제
|
PT2200606T
(pt)
*
|
2007-09-10 |
2017-12-13 |
Janssen Pharmaceutica Nv |
Processo para a preparação de compostos úteis como inibidores de sglt
|
CN101855204B
(zh)
*
|
2007-09-21 |
2013-09-11 |
韩兀生物制药株式会社 |
N,n-二甲基亚氨二羰酸二酰胺二羧酸盐、其制备方法及其药物组合物
|
US8303573B2
(en)
|
2007-10-17 |
2012-11-06 |
The Invention Science Fund I, Llc |
Medical or veterinary digestive tract utilization systems and methods
|
US8789536B2
(en)
|
2007-10-17 |
2014-07-29 |
The Invention Science Fund I, Llc |
Medical or veterinary digestive tract utilization systems and methods
|
US8707964B2
(en)
|
2007-10-31 |
2014-04-29 |
The Invention Science Fund I, Llc |
Medical or veterinary digestive tract utilization systems and methods
|
US8808276B2
(en)
*
|
2007-10-23 |
2014-08-19 |
The Invention Science Fund I, Llc |
Adaptive dispensation in a digestive tract
|
US8808271B2
(en)
*
|
2007-10-31 |
2014-08-19 |
The Invention Science Fund I, Llc |
Medical or veterinary digestive tract utilization systems and methods
|
US8333754B2
(en)
*
|
2007-10-31 |
2012-12-18 |
The Invention Science Fund I, Llc |
Medical or veterinary digestive tract utilization systems and methods
|
US8109920B2
(en)
*
|
2007-10-31 |
2012-02-07 |
The Invention Science Fund I, Llc |
Medical or veterinary digestive tract utilization systems and methods
|
JP5571000B2
(ja)
*
|
2008-01-16 |
2014-08-13 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
メトフォルミンおよびmtp阻害剤の組み合わせ物
|
WO2009099734A1
(en)
*
|
2008-02-05 |
2009-08-13 |
Merck & Co., Inc. |
Pharmaceutical compositions of a combination of metformin and a dipeptidyl peptidase-iv inhibitor
|
EP2259676A4
(en)
*
|
2008-03-04 |
2011-03-16 |
Merck Sharp & Dohme |
PHARMACEUTICAL COMPOSITIONS OF A COMBINATION OF METFORMIN AND A DIPEPTIDYL PEPTIDASE-IV INHIBITOR
|
US8551524B2
(en)
*
|
2008-03-14 |
2013-10-08 |
Iycus, Llc |
Anti-diabetic combinations
|
FR2928836B1
(fr)
*
|
2008-03-21 |
2011-08-26 |
Servier Lab |
Forme galenique secable permettant une liberation modifiee du principe actif
|
CA2638240C
(en)
*
|
2008-08-29 |
2010-02-02 |
Alexander Macgregor |
Method of treating dysglycemia and glucose excursions
|
WO2010026467A2
(en)
|
2008-09-04 |
2010-03-11 |
Torrent Pharmaceuticals Ltd. |
Controlled release dosage form of high solubility active ingredient
|
US20100069887A1
(en)
*
|
2008-09-16 |
2010-03-18 |
Searete Llc, A Limited Liability Corporation Of The State Of Delaware |
Multiple chamber ex vivo adjustable-release final dosage form
|
US20100068283A1
(en)
|
2008-09-16 |
2010-03-18 |
Searete Llc, A Limited Liability Corporation Of The State Of Delaware |
Ex VIVO modifiable particle or polymeric material medicament carrier
|
US9056850B2
(en)
*
|
2008-10-17 |
2015-06-16 |
Janssen Pharmaceutica N.V. |
Process for the preparation of compounds useful as inhibitors of SGLT
|
EP2181705A1
(en)
|
2008-10-31 |
2010-05-05 |
Disphar International B.V. |
Sustained-release formulation of gliclazide
|
EP2387394B1
(en)
|
2009-01-14 |
2018-05-02 |
Corium International, Inc. |
Transdermal administration of tamsulosin
|
EP2403487A2
(en)
*
|
2009-03-04 |
2012-01-11 |
Fdc Limited |
Oral controlled release dosage forms for water soluble drugs
|
US20110009347A1
(en)
|
2009-07-08 |
2011-01-13 |
Yin Liang |
Combination therapy for the treatment of diabetes
|
WO2011003976A1
(en)
|
2009-07-10 |
2011-01-13 |
Janssen Pharmaceutica Nv |
CRYSTALLISATION PROCESS FOR 1-(ß-D-GLUCOPYRANOSYL)-4-METHYL-3-[5-(4-FLUOROPHENYL)-2-THIENYLMETHYL] BENZENE
|
WO2011008054A2
(ko)
*
|
2009-07-17 |
2011-01-20 |
한올바이오파마주식회사 |
N,n-디메틸 이미도디카르본이미딕 디아미드의 부틸산염, 이의 제조방법, 이를 포함하는 약제학적 조성물 및 이를 포함하는 복합제제
|
WO2011008053A2
(ko)
*
|
2009-07-17 |
2011-01-20 |
한올바이오파마주식회사 |
N,n-디메틸 이미도디카르본이미딕 디아미드의 프로피온산염, 이의 제조방법, 이를 포함하는 약제학적 조성물 및 이를 포함하는 복합제제
|
CA2777528C
(en)
*
|
2009-10-14 |
2018-09-18 |
Janssen Pharmaceutica Nv |
Process for the preparation of compounds useful as inhibitors of sglt2
|
WO2011060256A2
(en)
|
2009-11-13 |
2011-05-19 |
Bristol-Myers Squibb Company |
Bilayer tablet formulations
|
RU2564901C2
(ru)
*
|
2009-11-13 |
2015-10-10 |
Бристол-Майерс Сквибб Кампани |
Композиции метформина с уменьшенной массой
|
WO2011061616A2
(en)
*
|
2009-11-23 |
2011-05-26 |
Micro Labs Limited |
Extended release compositions containing tolterodine and process for preparing the same
|
US8581001B2
(en)
|
2010-04-16 |
2013-11-12 |
Codman & Shurtleff |
Metformin-cysteine prodrug
|
WO2011143296A1
(en)
|
2010-05-11 |
2011-11-17 |
Janssen Pharmaceutica Nv |
Pharmaceutical formulations comprising 1 - (beta-d-glucopyranosyl) - 2 -thienylmethylbenzene derivatives as inhibitors of sglt
|
WO2011159824A1
(en)
|
2010-06-16 |
2011-12-22 |
Allergan, Inc. |
Composition and method for treating overactive bladder
|
US20120009259A1
(en)
*
|
2010-07-06 |
2012-01-12 |
Urbain Alfons Clementina Delaet |
Formulation for co-therapy treatment of diabetes
|
RU2016125229A
(ru)
|
2010-07-09 |
2018-12-04 |
БиЭйчВи ФАРМА, ИНК. |
Комбинированная система доставки с немедленным/замедленным высвобождением для лекарственных средств с коротким периодом полувыведения, в том числе для ремоглифлозина
|
JP2013538807A
(ja)
*
|
2010-09-01 |
2013-10-17 |
ルピン・リミテッド |
メトホルミンおよびピオグリタゾンを含む医薬組成物
|
US11974971B2
(en)
|
2011-01-07 |
2024-05-07 |
Anji Pharmaceuticals Inc. |
Compositions and methods for treating metabolic disorders
|
ES2834986T3
(es)
|
2011-01-07 |
2021-06-21 |
Anji Pharma Us Llc |
Terapias basadas en ligandos de receptores quimiosensoriales
|
US9480663B2
(en)
|
2011-01-07 |
2016-11-01 |
Elcelyx Therapeutics, Inc. |
Biguanide compositions and methods of treating metabolic disorders
|
US11759441B2
(en)
|
2011-01-07 |
2023-09-19 |
Anji Pharmaceuticals Inc. |
Biguanide compositions and methods of treating metabolic disorders
|
US9211263B2
(en)
|
2012-01-06 |
2015-12-15 |
Elcelyx Therapeutics, Inc. |
Compositions and methods of treating metabolic disorders
|
US8796338B2
(en)
|
2011-01-07 |
2014-08-05 |
Elcelyx Therapeutics, Inc |
Biguanide compositions and methods of treating metabolic disorders
|
US9572784B2
(en)
|
2011-01-07 |
2017-02-21 |
Elcelyx Therapeutics, Inc. |
Compositions comprising statins, biguanides and further agents for reducing cardiometabolic risk
|
UY33937A
(es)
|
2011-03-07 |
2012-09-28 |
Boehringer Ingelheim Int |
Composiciones farmacéuticas que contienen inhibidores de dpp-4 y/o sglt-2 y metformina
|
PL2697218T3
(pl)
|
2011-04-13 |
2016-11-30 |
|
Sposób wytwarzania związków użytecznych, jako inhibitory SGLT2
|
TWI542596B
(zh)
|
2011-05-09 |
2016-07-21 |
健生藥品公司 |
(2s,3r,4r,5s,6r)-2-(3-((5-(4-氟苯基)噻吩-2-基)甲基)-4-甲基苯基)-6-(羥甲基)四氫-2h-哌喃-3,4,5-三醇之l-脯胺酸及檸檬酸共晶體
|
US8858963B1
(en)
|
2011-05-17 |
2014-10-14 |
Mallinckrodt Llc |
Tamper resistant composition comprising hydrocodone and acetaminophen for rapid onset and extended duration of analgesia
|
US8658631B1
(en)
|
2011-05-17 |
2014-02-25 |
Mallinckrodt Llc |
Combination composition comprising oxycodone and acetaminophen for rapid onset and extended duration of analgesia
|
CN103702664B
(zh)
*
|
2011-07-26 |
2016-10-19 |
柳韩洋行 |
通过两相控释系统的含普瑞巴林的缓释片
|
BR112014016808B1
(pt)
|
2012-01-06 |
2022-01-11 |
Anji Pharma (Us) Llc |
Uso de um composto de biguanida para a fabricação de um medicamento para baixar os níveis de glicose no sangue e para o tratamento de um distúrbio do metabolismo de glicose
|
KR102231554B1
(ko)
|
2012-01-06 |
2021-03-23 |
앤지 파마 유에스 엘엘씨 |
대사 장애를 치료하는 조성물 및 방법
|
US9555001B2
(en)
|
2012-03-07 |
2017-01-31 |
Boehringer Ingelheim International Gmbh |
Pharmaceutical composition and uses thereof
|
EP2638898A1
(en)
|
2012-03-16 |
2013-09-18 |
Sanovel Ilac Sanayi ve Ticaret A.S. |
Metformin and Pioglitazone Formulation with Different Release Profiles
|
DE102012102414A1
(de)
*
|
2012-03-21 |
2013-10-10 |
Michael Dittgen |
Pharmazeutische Zusammensetzung für die einmal tägliche Anwendung antidiabetischer Arzneimittel wie Metformin mit Zwei-Puls-Freisetzung
|
WO2014014427A1
(en)
|
2012-07-16 |
2014-01-23 |
Mahmut Bilgic |
Modified release pharmaceutical tablet formulations
|
US20140037816A1
(en)
*
|
2012-07-31 |
2014-02-06 |
Hercules Incorporated |
Stabilized multiphase aqueous compositions
|
WO2014154643A1
(en)
*
|
2013-03-25 |
2014-10-02 |
Sanovel Ilac Sanayi Ve Ticaret A.S. |
Extended release formulations of metformin
|
EP3033075A1
(en)
|
2013-03-26 |
2016-06-22 |
Wockhardt Limited |
Solid oral pharmaceutical compositions comprising fixed dose combination of metformin and sitagliptin or salts thereof
|
US20150366863A1
(en)
|
2013-03-28 |
2015-12-24 |
Wockhardt Limited |
Solid oral pharmaceutical compositions comprising fixed dose combination of metformin and sitagliptin or salts thereof
|
JP5775970B2
(ja)
*
|
2013-05-31 |
2015-09-09 |
久光製薬株式会社 |
口腔貼付剤
|
KR101597004B1
(ko)
|
2013-07-25 |
2016-02-23 |
씨제이헬스케어 주식회사 |
서방형 메트포르민과 속방형 HMG-CoA 환원효소 억제제를 포함하는 복합제제
|
EP3137062A4
(en)
*
|
2014-04-29 |
2018-01-03 |
Matripharm Inc. |
Monolithic tablets based on carboxyl polymeric complexes for controlled drug release
|
US20170182070A1
(en)
|
2014-10-08 |
2017-06-29 |
Mayne Pharma International Pty Ltd. |
Controlled Release Doxycycline
|
WO2016073615A1
(en)
|
2014-11-07 |
2016-05-12 |
Regents Of The University Of Minnesota |
Salts and compositions useful for treating disease
|
MA39929A
(fr)
|
2014-11-27 |
2016-06-01 |
Arven Ilac Sanayi Ve Ticaret As |
Comprimé multicouche comprenant de la metformine et du pioglitazone
|
US20170071970A1
(en)
|
2015-09-15 |
2017-03-16 |
Janssen Pharmaceutica Nv |
Co-therapy comprising canagliflozin and phentermine for the treatment of obesity and obesity related disorders
|
CA3001337C
(en)
|
2015-10-09 |
2023-12-12 |
Reckitt Benckiser Llc |
Pharmaceutical formulation
|
JP7418958B2
(ja)
|
2016-03-17 |
2024-01-22 |
チオジェネシス セラピューティクス, インコーポレイテッド |
システアミンの制御放出のための組成物及びシステアミン感受性障害の全身治療
|
TR201620309A2
(tr)
|
2016-12-30 |
2018-07-23 |
Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi |
Metformi̇n hi̇droklori̇t ve pi̇ogli̇tazon hi̇droklori̇ti̇n farmasöti̇k bi̇leşi̇mleri̇
|
UA125535C2
(uk)
|
2017-07-17 |
2022-04-13 |
Елі Ліллі Енд Компані |
Фармацевтичні композиції
|
WO2019018158A1
(en)
|
2017-07-17 |
2019-01-24 |
Eli Lilly And Company |
PHARMACEUTICAL COMPOSITIONS
|
EP3661489A4
(en)
*
|
2017-08-02 |
2021-08-04 |
Nanyang Technological University |
FLOATABLE PHARMACEUTICAL MICROCAPSULE COMPOSITION
|
CN111683684B
(zh)
|
2017-09-20 |
2024-07-02 |
硫创治疗公司 |
用于治疗半胱胺敏感性病症的方法
|
US11911513B2
(en)
|
2018-05-23 |
2024-02-27 |
Shanghai Wd Pharmaceutical Co., Ltd |
Controlled-release system of active pharmaceutical ingredient and preparation method therefor
|
JP7125791B2
(ja)
|
2018-05-23 |
2022-08-25 |
シャンハイ ダブリュディー ファーマシューティカル カンパニー,リミティド |
活性薬物成分の放出制御システムおよびその製造方法
|
CN114191307A
(zh)
|
2020-09-17 |
2022-03-18 |
上海汉都医药科技有限公司 |
一种口腔滞留装置及其制备方法
|
EP3810111A4
(en)
|
2018-06-19 |
2022-03-23 |
National University of Singapore |
FORMULATIONS OF 5-HYDROXYTRYPTOPHAN (5-HTP) FOR BETTER BIOAVAILABILITY FOR DIFFERENT INDICATIONS
|
CN110354090B
(zh)
*
|
2019-07-29 |
2021-10-01 |
石药集团欧意药业有限公司 |
一种盐酸二甲双胍缓释片及其制备方法
|
WO2021042278A1
(zh)
*
|
2019-09-04 |
2021-03-11 |
鲁南贝特制药有限公司 |
一种阿昔莫司多单元缓释微丸片及其制备方法
|
EP3932974B1
(en)
*
|
2020-06-30 |
2023-02-22 |
Fujifilm Business Innovation Corp. |
Biodegradable resin particle
|
MX2024001390A
(es)
|
2021-07-30 |
2024-05-17 |
Evecxia Therapeutics Inc |
Formas de dosificacion gastrorretentivas de 5-hidroxitriptofano.
|
CN113662940B
(zh)
*
|
2021-09-02 |
2023-03-24 |
福州大学 |
一种盐酸二甲双胍和TGF-β抑制剂自组装的纳米材料
|
EP4392031A1
(en)
|
2021-10-14 |
2024-07-03 |
Evecxia Therapeutics, Inc. |
A method for optimizing 5-hydroxytryptamine function in the brain for therapeutic purposes
|
IT202100031691A1
(it)
|
2021-12-17 |
2023-06-17 |
I B N Savio S R L |
Processo produttivo di compresse a rilascio sostenuto di metformina
|
CN114404376A
(zh)
*
|
2022-03-16 |
2022-04-29 |
成都恒瑞制药有限公司 |
一种盐酸二甲双胍缓释片剂及其制备方法
|
EP4385502A1
(en)
|
2022-12-15 |
2024-06-19 |
Sanovel Ilac Sanayi Ve Ticaret A.S. |
A pharmaceutical formulation comprising metformin, pioglitazone and a sglt-2 inhibitor
|